Cough, Sneeze, Tissue Please
If you wake up in the morning with a cough and the sniffles, should you go to work and take a chance of passing an illness on to your co-workers? One research company in Israel is making it easier for you to decide whether to stay at home or go into the office when you’re feeling under the weather. Azure PCR, located in Jerusalem, is changing the way the world makes those decisions. According to CEO Aron Cohen, the company is developing a test that can put immediate results into the hands of the users. No more standing in line at the doctor or waiting for lab tests to come back with this streamlined kit that can detect, diagnose and track disease around the world.
Azure PCR has been coordinating its DNA analysis technology with international institutions and hopes that it will be used to prevent the spread of infectious diseases and viruses throughout the world. It can also be used for genetic screening and to detect water, food and soil contaminants as well as agents of bio-warfare. The process consists of three steps, which are to take a sample of the DNA from either blood or urine, test the DNA and then analyze the results. Instead of taking days to diagnose, the results are immediate, meaning there is no need to wait for necessary treatment.
Putting a Lid on Worldwide Disease
Faster treatment can be huge for future pandemic outbreaks in the developing world. During the swine flu and SARS epidemics, it took about six to eighteen months for the diseases to reach the West. When used as an “early warning system,” the automated analysis technique can diagnose viral and bacterial diseases and attack them with targeted vaccination programs.
Fast Results at Reduced Cost
Since 2010, Azure PCR has used its technology to test more than 500,000 samples. Users will be able to accurately diagnose various types of illnesses, from urinary tract infections to respiratory ailments, for fast treatment options. This will not only improve people’s lives by nipping worldwide diseases in the bud, but will reduce costs related to skilled medical personnel.